| 87582 |
Infectious agent detection by nucleic acid (DNA or RNA); Mycoplasma pneumoniae, quantification |
nan |
| 87591 |
Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique |
|
| 87592 |
Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, quantification |
|
| 87623 |
Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), low-risk types (eg, 6, 11, 42, 43, 44) |
|
| 87624 |
Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), high-risk types (eg, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68), pooled result |
|
| 87625 |
Infectious agent detection by nucleic acid (DNA or RNA); Human Papillomavirus (HPV), types 16 and 18 only, includes type 45, if performed |
|
| 87631 |
Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus) |
|
| 87634 |
Infectious agent detection by nucleic acid (DNA or RNA); respiratory syncytial virus, amplified probe technique |
|
| 87635 |
Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease ºCOVID-19»), amplified probe technique |
|
| 87636 |
Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease ºCOVID-19») and influenza virus types A and B, multiplex ampl |
|
| 87637 |
Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease ºCOVID-19»), influenza virus types A and B, and respiratory s |
|
| 87640 |
Infectious agent detection by nucleic acid (DNA or RNA); Staphylococcus aureus, amplified probe technique |
|
| 87641 |
Infectious agent detection by nucleic acid (DNA or RNA); Staphylococcus aureus, methicillin resistant, amplified probe technique |
|
| 87650 |
Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group A, direct probe technique |
nan |
| 87652 |
Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group A, quantification |
nan |
| 87653 |
Infectious agent detection by nucleic acid (DNA or RNA); Streptococcus, group B, amplified probe technique |
|
| 87660 |
Infectious agent detection by nucleic acid (DNA or RNA); Trichomonas vaginalis, direct probe technique |
|
| 87661 |
Infectious agent detection by nucleic acid (DNA or RNA); Trichomonas vaginalis, amplified probe technique |
|
| 87662 |
Infectious agent detection by nucleic acid (DNA or RNA); Zika virus, amplified probe technique |
|
| 87797 |
Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; direct probe technique, each organism |
|
| 87798 |
Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique, each organism |
|
| 87799 |
Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; quantification, each organism |
|
| 87800 |
Infectious agent detection by nucleic acid (DNA or RNA), multiple organisms; direct probe(s) technique |
|
| 87801 |
Infectious agent detection by nucleic acid (DNA or RNA), multiple organisms; amplified probe(s) technique |
|
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be p |
|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease ºcovid-19»), amplified probe technique, making use of high th Facility |
|
| U0005 |
INFECTIOUS AGENT DETECTION BY NUCLEIC ACID (DNA OR RNA); SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) (CORONAVIRUS DISEASE [COVID-19]), AMPLIFIED PROBE TECHNIQUE, CDC OR NON-CDC, MAKING USE OF HIGH THROUGHPUT TECHNOLOGIES, COMPLETED WITHIN 2 CALENDAR DAYS FROM DATE OF SPECIMEN COLLECTION (LIST SEPARATELY IN ADDITION TO EITHER HCPCS CODE U0003 OR U0004) AS DESCRIBED BY CMS-2020-01-R2 |
|
| 87468 |
Infectious agent detection by nucleic acid (DNA or RNA); Anaplasma phagocytophilum, amplified probe technique |
|
| 87469 |
Infectious agent detection by nucleic acid (DNA or RNA); Babesia microti, amplified probe technique |
|
| 87478 |
Infectious agent detection by nucleic acid (DNA or RNA); Borrelia miyamotoi, amplified probe technique |
|